Goldman Sachs Group Inc Gritstone Bio, Inc. Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,159,891 shares of GRTS stock, worth $23,197. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,159,891
Previous 476,798 143.27%
Holding current value
$23,197
Previous $1.23 Million 41.31%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$0.62 - $2.35 $423,517 - $1.61 Million
683,093 Added 143.27%
1,159,891 $719,000
Q1 2024

May 15, 2024
BUY
$1.96 - $2.9 $665,702 - $984,967
339,644 Added 247.64%
476,798 $1.23 Million
Q4 2023

Feb 13, 2024
SELL
$1.28 - $2.85 $62,152 - $138,387
-48,557 Reduced 26.15%
137,154 $279,000
Q3 2023

May 14, 2024
BUY
$1.19 - $2.26 $57,782 - $109,738
48,557 Added 35.4%
185,711 $319,000
Q3 2023

Nov 14, 2023
BUY
$1.19 - $2.26 $66,030 - $125,402
55,488 Added 42.61%
185,711 $319,000
Q2 2023

May 14, 2024
SELL
$1.66 - $3.03 $241,599 - $440,992
-145,542 Reduced 52.78%
130,223 $253,000
Q2 2023

Aug 14, 2023
SELL
$1.66 - $3.03 $241,599 - $440,992
-145,542 Reduced 52.78%
130,223 $253,000
Q1 2023

May 14, 2024
BUY
$2.13 - $3.74 $321,487 - $564,489
150,933 Added 120.91%
275,765 $766,000
Q1 2023

May 11, 2023
BUY
$2.13 - $3.74 $321,487 - $564,489
150,933 Added 120.91%
275,765 $766,000
Q4 2022

May 14, 2024
BUY
$2.17 - $3.92 $1,618 - $2,924
746 Added 0.6%
124,832 $430,000
Q4 2022

Feb 13, 2023
BUY
$2.17 - $3.92 $1,618 - $2,924
746 Added 0.6%
124,832 $430,000
Q3 2022

May 14, 2024
SELL
$2.46 - $4.75 $78,545 - $151,662
-31,929 Reduced 20.47%
124,086 $319,000
Q3 2022

Nov 10, 2022
SELL
$2.46 - $4.75 $78,545 - $151,662
-31,929 Reduced 20.47%
124,086 $0
Q2 2022

May 14, 2024
BUY
$1.77 - $4.34 $33,383 - $81,856
18,861 Added 13.75%
156,015 $378,000
Q2 2022

Aug 15, 2022
SELL
$1.77 - $4.34 $236,971 - $581,047
-133,882 Reduced 46.18%
156,015 $378,000
Q1 2022

May 16, 2022
SELL
$4.03 - $12.19 $612,011 - $1.85 Million
-151,864 Reduced 34.38%
289,897 $1.19 Million
Q4 2021

Feb 14, 2022
BUY
$8.76 - $13.71 $3.32 Million - $5.2 Million
378,936 Added 603.16%
441,761 $5.68 Million
Q3 2021

Nov 10, 2021
BUY
$6.41 - $13.54 $402,708 - $850,650
62,825 New
62,825 $679,000

Others Institutions Holding GRTS

# of Institutions
77
Shares Held
37.5M
Call Options Held
1.46M
Put Options Held
168K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $1.46M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email